Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates.
about
Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges.Review of "the Twelfth West Coast Retrovirus Meeting" and "the Twenty-third Annual Symposium on Nonhuman Primate Models for AIDS".Animal and human mucosal tissue models to study HIV biomedical interventions: can we predict success?Comparison of the vaginal environment of Macaca mulatta and Macaca nemestrina throughout the menstrual cycleParsimonious Determination of the Optimal Infectious Dose of a Pathogen for Nonhuman Primate ModelsProfile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to datePrevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovirT cell chemo-vaccination effects after repeated mucosal SHIV exposures and oral pre-exposure prophylaxisEngineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-NSurrogates of protection in repeated low-dose challenge experiments.On modeling HIV and T cells in vivo: assessing causal estimators in vaccine trials.Which topical microbicides for blocking HIV-1 transmission will work in the real world?Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides.Antiretroviral therapy for prevention of HIV infection: new clues from an animal model.SHIV susceptibility changes during the menstrual cycle of pigtail macaques.A polyvalent Clade B virus-like particle HIV vaccine combined with partially protective oral preexposure prophylaxis prevents simian-human immunodeficiency virus Infection in macaques and primes for virus-amplified immunityShort communication: Viremic control is independent of repeated low-dose SHIVSF162p3 exposures.The role of exposure history on HIV acquisition: insights from repeated low-dose challenge studies.Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen.Increased susceptibility to vaginal simian/human immunodeficiency virus transmission in pig-tailed macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalisNatural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitors.Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaquesAn intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaquesDurable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissueA long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge.Characterization of the Genital Microenvironment of Female Rhesus Macaques Prior to and After SIV InfectionPreclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture.HIV prevention by oral preexposure prophylaxis.Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation.A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques.Development of a pigtail macaque model of sexually transmitted infection/HIV coinfection using Chlamydia trachomatis, Trichomonas vaginalis, and SHIV(SF162P3)Short Communication: Practical Experience with Analysis and Design of Repeat Low-Dose SHIVSF162P3 Exposure Studies in Female Pigtail Macaques with Varying Susceptibility During Menstrual Cycling.Biology of mucosally transmitted sexual infection-translating the basic science into novel HIV intervention: a workshop summary.Nondaily preexposure prophylaxis for HIV prevention.Susceptibility to repeated, low-dose, rectal SHIVSF162P3 challenge is independent of TRIM5 genotype in rhesus macaques.Animal models for microbicide studies.Lack of prophylactic efficacy of oral maraviroc in macaques despite high drug concentrations in rectal tissuesIntravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.Microbicide safety/efficacy studies in animals: macaques and small animal models.Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1.
P2860
Q24812967-CD62D72A-55CC-4510-9A5D-43F2A77B924AQ25256613-935BB10C-1E30-46E2-A040-09D3B1D15B35Q26777022-6F78C94E-8351-4D9C-BB89-F2694A3CCCEDQ26827574-D4E0F4AB-56A7-49DD-BAE4-0D4F6B0FDB9BQ27318212-35F250FE-E516-4C96-840A-7CCB7BD671E4Q28079025-560BEFA8-F532-4175-BF44-ACEA20529107Q28472146-329DAF07-EB14-4A30-8055-06EB6E7278B3Q28477909-91DF77E8-6969-487E-9141-8DCA4F48581EQ30357096-6116EC5D-5BDA-45A1-B427-A07B196CB534Q30371157-C0BCFE15-FEDB-47DC-B767-96DE774B8831Q33247446-94E5189E-8CCE-4A91-A90E-1B89DEAFD6DBQ33253661-8AD2F0AB-9F58-46E4-9710-3C859D9C4904Q33260514-3633BFA2-D39A-491F-B43B-F4FA5A84F029Q33318541-CCA8092B-1686-41FC-A619-4866824B4F22Q34243579-0DCDEFA2-CC0A-4E23-80B8-E614F2D7779BQ34399535-D2B5E21E-CA79-4D5E-90DA-83F531C24402Q34399723-F1C7DEF9-B1B3-41DA-B6FB-4DB6168F29EDQ34488291-B9CD2C53-4C89-4462-83E0-21EE9E5F46A8Q34506545-E925F2B1-26CD-44F9-9934-F38B9256F952Q34736553-4EA06A68-CD33-4107-94A0-F35B61968A36Q35077568-7A670AD7-2FE4-480D-B6A8-83D8E4F8749BQ35101333-D936B9A6-7BEA-41DD-ACF1-9BA9DB1ED0BDQ35345363-48392FE8-D754-4595-AA4D-011941608947Q35665851-DDFD3B93-A51F-4FC8-8853-CDA2E7F9AB7EQ35667426-18B8DDC6-2DAC-4C26-829C-64E94BB876E7Q35750861-1A1402C7-C2F0-4D31-9CDB-10BCAC8D41D2Q35759112-85AD82D0-08D8-4FF8-816C-19A4E8671C96Q35765743-511F1498-8C22-4E85-BC7B-7B513847737BQ35861236-5DB45AA6-7D72-42AB-B0F5-A64FDD713DD8Q36023146-2C00BEAC-D6B4-4CD4-9927-CDBF64A10DA7Q36108441-13E0A482-F237-4E60-BDD4-6E24028EDE53Q36259499-485EFAFC-5ED6-4B96-8A46-C65073CC8AF6Q36358993-6220C203-E597-41BF-A6DA-EDA50CCFE612Q36669377-3D433D20-9932-4192-99A3-80DB7E70F205Q36937885-CCCB0458-12B6-4CE5-AC44-06382F7E3B29Q37017688-9EB1D264-63F4-4E65-A959-0EA72726F3F7Q37123335-AB1CD4CB-1E6C-4F1F-9536-8C963631C952Q37218578-131C267D-D151-4529-BE43-024710960A56Q37223070-B818D2D2-C8DE-4FA6-8326-AF80D12C6ED8Q37273086-BE5F7908-658B-410E-9EA6-02902E0466F6
P2860
Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Multiple vaginal exposures to ...... ventions in nonhuman primates.
@en
Multiple vaginal exposures to ...... ventions in nonhuman primates.
@nl
type
label
Multiple vaginal exposures to ...... ventions in nonhuman primates.
@en
Multiple vaginal exposures to ...... ventions in nonhuman primates.
@nl
prefLabel
Multiple vaginal exposures to ...... ventions in nonhuman primates.
@en
Multiple vaginal exposures to ...... ventions in nonhuman primates.
@nl
P2093
P356
P1476
Multiple vaginal exposures to ...... ventions in nonhuman primates.
@en
P2093
Caryn N Kim
Debra R Adams
Eddie Jackson
Jennifer K Pullium
Lisa A Grohskopf
Michael Monsour
Ron A Otten
Sal Butera
Thomas M Folks
P304
P356
10.1086/426452
P407
P577
2004-12-09T00:00:00Z